Dipalmitoylphosphatidylcholine in the hearts of mice does not correlate with expression of the autoimmune disease lupus
Main Article Content
Abstract
Introduction The lung surfactant dipalmitoylphosphatidylcholine leaks into the blood, settling on the luminal aspect of blood vessels to create active hydrophobic spots. Nanobubbles are formed at these spots from dissolved gas. We hypothesized that contact between a large molecule in the blood at the gaseous/liquid interface would disrupt the molecule’s tertiary structure. An exposed epitope may then prompt an autoimmune response. The double cause hypothesis suggests that high level of DPPC is a prerequisite for the development of autoimmune disease. The double cause hypothesis was supported in a study using diabetic mice.
Methods dipalmitoylphosphatidylcholine content was determined in the hearts of mice which suffered lupus: those which contracted lupus (lpr) and their control which would contract the disease much later on (mjp) and healthy control mice strain (C57/BL6).
Results dipalmitoylphosphatidylcholine content (mg/g, mean ± SD) in the three groups was: for lpr 32.1 ± 4.7, for mjp 36.1 ± 7.7 and for the control C57/BL6 40.3 ± 10.4. There was no significant difference between the three groups.
Discussion We suggest that the difference between diabetic mice and lupus is due to the nature of autoantigens: a protein in diabetic and nuclear, ribonucleoproteins and ribosomes in lupus. Possibly the distortion at the gaseous/liquid interface is more pronounced in proteins.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Arieli R. Nanobubbles Form at Active Hydrophobic Spots on the Luminal Aspect of Blood Vessels: Consequences for Decompression Illness in Diving and Possible Implications for Autoimmune Disease-An Overview. Front Physiol. 2017;8:591. Published 2017 Aug 15. doi:10.3389/fphys.2017.0 0591
3. Arieli R. Was the appearance of surfactants in air breathing vertebrates ultimately the cause of decompression sickness and autoimmune disease?. Respir Physiol Neurobiol. 2015;206:15-18. doi:10.10 16/j.resp.2014.11.008
4. Sutherland S. How Auto-Immunity Starts. Sci Am. 2021;325(3):34. doi:10.1038/scientificamer ican0921-34
5. Moyer M. Women at Risk. Sci Am. 2021; 325(3):40. doi:10.1038/scientificamerican0921-40.
6. Arieli R, Khatib S. Dipalmitoylphosphatidylcholine in the heart of mice with lupus might support the hypothesis of dual causes of autoimmune diseases. Respir Physiol Neurobiol. 2022;300:103871. doi:10.1016/j.resp.20 22.103871
7. Arieli R., Khatib S., Khatib A., Bukovetzky E., Gottfried O.D. (2020). Is the probable spillage of the lung surfactant dipalmitoylphosphatidylcholine the ultimate source of diabetes type1? Respir. Physiol. Neurobiol. 286: 103615. doi: 10.1016/j.resp.2020.1 03615.
8. Arieli R, Khatib S, Tarabeh A, Bakry D, Bukovetzky E, Gottfried OD (2023). Testing the Double Cause Hypothesis for autoimmune diseases, dipalmitoylphosphatidylcholine should be measured in plasma or blood vessels of diabetes Type 1? Medical Res. Arch. 11(4). doi.org/10.18103/mra.v1 1i4.3562.
9. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994;179(4):1317-1330. doi:10.1084/jem.17 9.4.1317.